Sol Gel Techn Is 10 Stock Fundamentals
| 4SG Stock | EUR 0.39 0.04 11.43% |
SOL GEL TECHN IS 10 fundamentals help investors to digest information that contributes to SOL-GEL TECHN's financial success or failures. It also enables traders to predict the movement of SOL-GEL Stock. The fundamental analysis module provides a way to measure SOL-GEL TECHN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SOL-GEL TECHN stock.
SOL-GEL |
SOL GEL TECHN IS 10 Company Shares Outstanding Analysis
SOL-GEL TECHN's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current SOL-GEL TECHN Shares Outstanding | 23.13 M |
Most of SOL-GEL TECHN's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SOL GEL TECHN IS 10 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, SOL GEL TECHN IS 10 has 23.13 M of shares currently outstending. This is 87.19% lower than that of the Healthcare sector and 78.35% lower than that of the Biotechnology industry. The shares outstanding for all Germany stocks is 95.96% higher than that of the company.
SOL GEL TECHN Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SOL-GEL TECHN's current stock value. Our valuation model uses many indicators to compare SOL-GEL TECHN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SOL-GEL TECHN competition to find correlations between indicators driving SOL-GEL TECHN's intrinsic value. More Info.SOL GEL TECHN IS 10 is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SOL GEL TECHN IS 10 is roughly 2.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SOL-GEL TECHN's earnings, one of the primary drivers of an investment's value.SOL-GEL Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SOL-GEL TECHN's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SOL-GEL TECHN could also be used in its relative valuation, which is a method of valuing SOL-GEL TECHN by comparing valuation metrics of similar companies.SOL GEL is currently under evaluation in shares outstanding category among its peers.
SOL-GEL Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0471 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.16 % | |||
| Shares Outstanding | 23.13 M | |||
| Shares Owned By Insiders | 74.06 % | |||
| Shares Owned By Institutions | 13.95 % | |||
| Revenue | 24.59 M | |||
| Gross Profit | 10.89 M | |||
| EBITDA | 4.75 M | |||
| Net Income | (27.21 M) | |||
| Cash And Equivalents | 38.88 M | |||
| Cash Per Share | 1.69 X | |||
| Total Debt | 1.61 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 8.02 X | |||
| Book Value Per Share | 2.05 X | |||
| Cash Flow From Operations | (27.03 M) | |||
| Earnings Per Share | 0.18 X | |||
| Target Price | 19.25 | |||
| Number Of Employees | 53 | |||
| Beta | 1.28 | |||
| Market Capitalization | 116.38 M | |||
| Z Score | 43.2 |
About SOL-GEL TECHN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SOL GEL TECHN IS 10's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SOL-GEL TECHN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SOL GEL TECHN IS 10 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company was incorporated in 1997 and is headquartered in Ness Ziona, Israel. SOL GEL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 65 people.
Currently Active Assets on Macroaxis
Other Information on Investing in SOL-GEL Stock
SOL-GEL TECHN financial ratios help investors to determine whether SOL-GEL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SOL-GEL with respect to the benefits of owning SOL-GEL TECHN security.